Trial intelligence / Profile preview

TEAM-AMI: BMMSC and Atorvastatin in Acute Myocardial Infarction

NCT03047772Phase 2Unknown

Start
Mar 2018
Primary completion
Dec 2018
Modality
Stem Cell Therapies, Small Molecules
01

Overview

A Phase 2 trial of atorvastatin, autologous bone-marrow mesenchymal stem cells in acute myocardial infarction (AMI). Status: unknown.

02

Drugs

atorvastatinautologous bone-marrow mesenchymal stem cells
03

Conditions

acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT03047772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03047772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call